Sort
82,697 grants matching “vaccine development”
Primate Studies
$882,699Preston A Marx · University Of Pennsylvania · P01 · FY2009 · AI
Efficacy of Strain 68-1 RhCMV Vectors Expressing 5' Leader Polypeptides
$882,566Scott G Hansen · Oregon Health & Science University · R01 · FY2016 · AI
Targeting bacterial cell wall biogenesis for the development of novel antimicrob
$882,519Thomas G Bernhardt · Harvard Medical School · U19 · FY2018 · AI
Development of Aersolized Vaccines
$882,379Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Development Of Flow Cytometric Technologies For Immune Assays
$882,378Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Non-Human Primate Core
$882,378Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIC · FY2010 · AI
Clonal Analysis of the Human B Cell Response to HIV
$882,141James E Crowe · Vanderbilt University · U01 · FY2009 · AI
Inhibitors of Anthrax Lethal Factor Metalloproteinase
$882,133Alan Thomas Johnson · Panthera Biopharma, Llc · R44 · FY2008 · AI
High Precision System Analysis of Infant Immune Responses
$882,108Octavio Ramilo · Research Inst Nationwide Children'S Hosp · U01 · FY2018 · AI
Therapeutic Use of an Enhanced Form of CD4-Ig
$882,067Michael R. Farzan · Scripps Florida · R37 · FY2020 · AI
Maximizing germinal centers and somatic hypermutation to HIV Env immunogens
$882,023Shane P Crotty · La Jolla Institute For Immunology · R37 · FY2024 · AI
Structural characterization of MPER-TM immunogens
$881,996Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2025 · AI
Investigation into the activation of multiple bnAb precursors using structure-designed immunogens and Ig knock-in mice
$881,947Amelia Escolano · Wistar Institute · R01 · FY2025 · AI
Cross talk between keratinocytes and skin-resident T-cells influences HSV recurrence
$881,878Jia Zhu · Fred Hutchinson Cancer Center · R01 · FY2024 · AI
Understanding the functional role of Myeloid Derived Suppressor cells in tuberculosis
$881,854Shabaana A. Khader · University Of Chicago · R01 · FY2024 · AI
Project 1: Definition of the structural principles underlying broadly protective humoral immunity to coronaviruses
$881,853David Veesler · University Of Washington · P01 · FY2022 · AI
B cell lineage directed rational vaccine strategies based on CAP256SU Env-Ab coevolution
$881,590Raiees Ahmad Andrabi · Scripps Research Institute, The · R01 · FY2022 · AI
Role of the GI microbiome in immune responses to oral SIV-DNA+SIV-polio Vaccine
$881,569Anna Aldovini · Boston Children'S Hospital · R56 · FY2016 · AI
Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity
$881,526Charles M. Rice · Rockefeller University · R01 · FY2022 · AI
Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens
$881,449Leonidas A Stamatatos · Seattle Biomedical Research Institute · U19 · FY2014 · AI
Optimizing AAV delivery of bNAbs for HIV prevention
$881,378Matthew Ryan Gardner · Emory University · R01 · FY2025 · AI
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
$881,222Roger Keith Reeves · Duke University · R01 · FY2021 · AI
Advanced Development of a Filovirus Vaccine
$881,157Benoit Callendret · Janessen Vaccines And Prevention, Bv · N01 · FY2018 · AI
NOVEL MUCOSAL VACCINE APPROACHES FOR PNEUMONIA KLEBSIELLA
$881,051Elizabeth Norton · Tulane University Of Louisiana · N01 · FY2023 · AI
Heritable immunization of the white-footed mouse reservoir of Lyme disease
$881,046Kevin Esvelt · Massachusetts Institute Of Technology · R01 · FY2023 · AI